Faculty

Andrea Burnett-Hartman

Affiliate Instructor, Epidemiology


Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BPH Microbiology & Ecology, Miami University (Ohio), 2000

Contact


Kaiser Permanente
Seattle, WA
View Website »

Research Interests

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.

Recent Publications (PubMed)

Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational Study.
(2024 Dec)
Ann Intern Med 177(12): 1621-1629
Levin TR, Jensen CD, Udaltsova N, Burnett-Hartman AA, Kamineni A, Chao CR, Schottinger JE, Ghai NR, Pocobelli G, White LL, Oliver M, Chowdhry H, Hixon BP, Badalov JM, Goldberg SR, Bradford SC, Quesenberry CP, Lee JK

Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study.
(2024 Oct 12)
Sci Rep 14(1): 23891
Denos M, Sun YQ, Brumpton BM, Li Y, Albanes D, Burnett-Hartman A, Campbell PT, Küry S, Li CI, White E, Samadder JN, Jenkins MA, Mai XM

Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk.
(2025 Jan 1)
Epidemiology 36(1): 126-138
Thomas CE, Lin Y, Kim M, Kawaguchi ES, Qu C, Um CY, Lynch BM, Van Guelpen B, Tsilidis K, Carreras-Torres R, van Duijnhoven FJB, Sakoda LC, Campbell PT, Tian Y, Chang-Claude J, Bézieau S, Budiarto A, Palmer JR, Newcomb PA, Casey G, Le Marchandz L, Giannakis M, Li CI, Gsur A, Newton C, Obón-Santacana M, Moreno V, Vodicka P, Brenner H, Hoffmeister M, Pellatt AJ, Schoen RE, Dimou N, Murphy N, Gunter MJ, Castellví-Bel S, Figueiredo JC, Chan AT, Song M, Li L, Bishop DT, Gruber SB, Baurley JW, Bien SA, Conti DV, Huyghe JR, Kundaje A, Su YR, Wang J, Keku TO, Woods MO, Berndt SI, Chanock SJ, Tangen CM, Wolk A, Burnett-Hartman A, Wu AH, White E, Devall MA, Díez-Obrero V, Drew DA, Giovannucci E, Hidaka A, Kim AE, Lewinger JP, Morrison J, Ose J, Papadimitriou N, Pardamean B, Peoples AR, Ruiz-Narvaez EA, Shcherbina A, Stern MC, Chen X, Thomas DC, Platz EA, Gauderman WJ, Peters U, Hsu L

Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
(2024 Dec 15)
Cancer 130(24): 4287-4297
Issaka RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, Clark CR, Del Vecchio NJ, Kamineni A, Neslund-Dudas C, Chubak J, Corley DA, Haas JS, Honda SA, Li CI, Winer RL, Pruitt SL

Identifying factors and causal chains associated with optimal implementation of Lynch syndrome tumor screening: An application of coincidence analysis.
(2024 Oct)
Genet Med 26(10): 101201
Cragun D, Salvati ZM, Schneider JL, Burnett-Hartman AN, Epstein MM, Hunter JE, Liang SY, Lowery J, Lu CY, Pawloski PA, Schlieder V, Sharaf RN, Williams MS, Rahm AK

Show complete publication list

In the News

No news articles at this time.